The use of cyclosporine in ocular inflammatory disorders
Nussenblatt, R.B.
Transplantation Proceedings 20(3 Suppl 4: 114-121
1988
ISSN/ISBN: 0041-1345 PMID: 3289201 Document Number: 321558
Document emailed within 1 workday
Related Documents
Tessler, H.H. 2002: Ocular inflammatory disease: use of topical and systemic anti-inflammatory agents Managed Care 11(1 Suppl): 12-15; Discussion: 24-27Tabbara, K.F.; Gee, S.S.; Alvarez, H. 1988: Ocular bioavailability of cyclosporine after oral administration Transplantation Proceedings 20(2 Suppl 2: 656-659
Orzechowski, R.F. 1974: Study guide. Inflammatory disorders. II. Pharmacology of anti-inflammatory agents American Journal of Pharmacy and the Sciences Supporting Public Health 146(5): 150-161
Nakase, H.; Matsuura, M.; Chiba, T. 2012: Effect of immunosuppressants on inflammatory bowel disease: tacrolimus and cyclosporine Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 324-328
Shalby, A.B.; Hamza, A.H.; Ahmed, H.H. 2012: New insights on the anti-inflammatory effect of some Egyptian plants against renal dysfunction induced by cyclosporine European Review for Medical and Pharmacological Sciences 16(4): 455-461
Kurup, S.K.; Chan, C-Chao. 2006: Mycobacterium-related ocular inflammatory disease: diagnosis and management Annals of the Academy of Medicine Singapore 35(3): 203-209
Cuchacovich, M.; Gatica, H.; Verdaguer, J.I.; Carreño, M.A.; Villarroel, F.; Verdaguer, J. 1999: Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin a Revista Medica de Chile 127(3): 277-285
Vyshegurov, I.K.; Anikhovskaia, I.A.; Batmanov, I.E.; Iakovlev, M.I. 2007: Intestinal endotoxin in the pathogenesis of ocular inflammatory diseases and the antiendoxin constituent of its treatment Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 12-14
Daheshia, M.; Kuklin, N.; Kanangat, S.; Manickan, E.; Rouse, B.T. 1997: Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10 Journal of Immunology 159(4): 1945-1952
Zagórski, Z. 1986: Application of benzotriazole for reduction of acute inflammatory reaction in experimental ocular chalcosis Klinika Oczna 88(7): 241-244
Balestrazzi, E.; Scorcia, G.; Ranieri, G. 1971: Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21-(pyridine-4-carboxylate) Annali di Ottalmologia E Clinica Oculistica 97(1): 15-22
Keith, C.G. 1993: Molecular biology in ocular disorders Medical Journal of Australia 158(9): 615-618
Pescosolido, N.; Parisi, F.; Buomprisco, G.; Librando, A. 2013: New therapies in common ocular surface disorders La Clinica Terapeutica 164(5): e405-e411
Chaĭka, L.A.; Povolotskaia, V.A. 1995: The effect of local corticosteroid therapy on ophthalmic tonus and ocular hydro- and hemodynamics in experimental inflammatory pathology Eksperimental'naia i Klinicheskaia Farmakologiia 58(3): 62-64
Roy, P. 2004: Stem cell transplants in ocular surface disorders Journal of the Indian Medical Association 102(1): 46
Berman, E.L. 1995: Clues in the eye: ocular signs of metabolic and nutritional disorders Geriatrics 50(7): 34-36; 43-44
Aretio, R.; García, A.; Vázquez, A.; Recio, F.; Corzo, J.E.; Lozano, F. 1995: Vision disorders and ocular lesions in an AIDS patient Enfermedades Infecciosas y Microbiologia Clinica 13(3): 183-185
Baranowska-George, T.; Zielińska, H. 1976: Space localization in cases of disorders of ocular motility in the horizontal plane Klinika Oczna 46(7): 749-754
Stuart, J.C.; Linn, J.G. 1985: Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders Annals of Ophthalmology 17(3): 190-192
Michalik, M. 1987: Spectral analyses in ocular microtremor in disorders of brain stem function Eeg-Emg Zeitschrift für Elektroenzephalographie Elektromyographie und verwandte Gebiete 18(1): 20-26